Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (431-440 of 605) with videos related to

Pageof 61
Sort By:
Breast Cancer Research and Treatment|August 21, 2021
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutationsJing Xu, Tanya E Keenan, Beth Overmoyer, et al.
Cancer Research|January 4, 2008
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriersBoning Gao, Xian-Jin Xie, Chunxian Huang, et al.
Annals of Surgical Oncology|May 12, 2025
ASO Visual Abstract: Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
JAMA Oncology|March 21, 2024
PARP Inhibitors for Breast Cancer Treatment: A ReviewStefania Morganti, Antonio Marra, Carmine De Angelis, et al.
Annals of Surgical Oncology|March 20, 2025
Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
NPJ Breast Cancer|June 19, 2020
Retinoblastoma protein expression and its predictors in triple-negative breast cancerJaymin M Patel, Andrew Goss, Judy E Garber, et al.
JCO Precision Oncology|December 12, 2024
Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With CancerKara K Landry, Michael J DeSarno, Lindsay Kipnis, et al.
Journal of Genetic Counseling|October 17, 2022
Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriersDanielle B McKenna, Pauleen Sanchez, Jacquelyn Powers, et al.
Nature Communications|June 8, 2023
Identification of BRCA1/2 mutation female carriers using circulating microRNA profilesKevin Elias, Urszula Smyczynska, Konrad Stawiski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancerSusan M Domchek, Gillian Mitchell, Geoffrey J Lindeman, et al.
Pageof 61

Showing results (431-440 of 605) with videos related to

Sort By:
Pageof 61
Breast Cancer Research and Treatment|August 21, 2021
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutationsJing Xu, Tanya E Keenan, Beth Overmoyer, et al.
Cancer Research|January 4, 2008
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriersBoning Gao, Xian-Jin Xie, Chunxian Huang, et al.
Annals of Surgical Oncology|May 12, 2025
ASO Visual Abstract: Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
JAMA Oncology|March 21, 2024
PARP Inhibitors for Breast Cancer Treatment: A ReviewStefania Morganti, Antonio Marra, Carmine De Angelis, et al.
Annals of Surgical Oncology|March 20, 2025
Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy RatesAnna Weiss, Maria Sol Rosito, Danielle Braun, et al.
NPJ Breast Cancer|June 19, 2020
Retinoblastoma protein expression and its predictors in triple-negative breast cancerJaymin M Patel, Andrew Goss, Judy E Garber, et al.
JCO Precision Oncology|December 12, 2024
Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With CancerKara K Landry, Michael J DeSarno, Lindsay Kipnis, et al.
Journal of Genetic Counseling|October 17, 2022
Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriersDanielle B McKenna, Pauleen Sanchez, Jacquelyn Powers, et al.
Nature Communications|June 8, 2023
Identification of BRCA1/2 mutation female carriers using circulating microRNA profilesKevin Elias, Urszula Smyczynska, Konrad Stawiski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancerSusan M Domchek, Gillian Mitchell, Geoffrey J Lindeman, et al.
Pageof 61